[I23-06] Fidanacogene elaparvovec (haemophilia B); assessment according to §35a Social Code Book (SGB) V; search for disease registries
Last updated 16.10.2023
Project no.:
I23-06
Commission:
Commission awarded on 27.06.2023 by the Federal Joint Committee (G-BA).
Report type:
Search for disease registries
Status:
Commission completed
Department/Division:
Information Management
Topic:
Haematology
Search for disease registries
When assessing whether a routine practice data collection according to the GSAV is necessary for new drugs, the feasibility and appropriateness of data collection is also examined by the G-BA. A systematic search for registries in the respective therapeutic indication to be investigated supports the decision-making process. Once a month, the G-BA selects a therapeutic indication for the systematic search for registries and commissions IQWiG.
https://dx.doi.org/10.60584/I23-06
Federal Joint Committee (G-BA)
2023-10-05 A G-BA decision was published.